Key facts
| Price (PPV) | 232 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | cytarabine |
| Class | Antineoplastic agents |
| ATC code | L01BC01 |
| Manufacturer | PFIZER MAROC |
| Presentation | Boîte de 1 Flacon de en verre Injectable |
| Nature | Médicament |
| Hospital price | 145.40 MAD |
| Data collected on | 9/8/2026 |
Indications
- Leucémies aiguës myéloblastiques notamment en rechute. - Leucémies aiguës myéloblastiques dites réfractaires (rechutant en cours de traitement). - Leucémies aiguës lymphoblastiques en rechute, et leucémies secondaires.
Find an open pharmacy
On-call pharmacies near you
About Aracytine 500 mg
Aracytine 500 mg belongs to the antineoplastic agents therapeutic class. In Morocco, this drug is marketed by PFIZER MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Aracytine 500 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Aracytine 500 mg
Answers to common questions from Moroccan patients about this drug.